Hepion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2…

Biotechnology
US, Edison [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Hepion Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Hepion Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Hepion Pharmaceuticals, Inc..

End of HEPA's Analysis
CIK: 1583771 CUSIP: 426897104 ISIN: US4268973025 LEI: - UEI: -
Secondary Listings
HEPA has no secondary listings inside our databases.